Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M42,671Revenue (TTM) $M4,649Net Margin (%)15.7Altman Z-Score14.1
Enterprise Value $M41,987EPS (TTM) $6.3Operating Margin %26.8Piotroski F-Score6
P/E(ttm)64.3Beneish M-Score-2.7Pre-tax Margin (%)26.7Higher ROA y-yY
Price/Book10.510-y EBITDA Growth Rate %--Quick Ratio3.0Cash flow > EarningsY
Price/Sales10.15-y EBITDA Growth Rate %--Current Ratio3.4Lower Leverage y-yY
Price/Free Cash Flow44.7y-y EBITDA Growth Rate %24.2ROA % (ttm)13.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)20.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M105ROIC % (ttm)23.4Gross Margin Increase y-yN

Gurus Latest Trades with REGN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
REGNJoel Greenblatt 2016-06-30 Add0.12%$331.05 - $427.2
($384.74)
$ 423.2210%Add 1094.10%30,151
REGNVanguard Health Care Fund 2016-06-30 Add0.08%$331.05 - $427.2
($384.74)
$ 423.2210%Add 3.46%3,279,190
REGNMario Gabelli 2016-06-30 Reduce$331.05 - $427.2
($384.74)
$ 423.2210%Reduce -1.04%1,329
REGNRon Baron 2016-06-30 Reduce$331.05 - $427.2
($384.74)
$ 423.2210%Reduce -0.48%4,987
REGNVanguard Health Care Fund 2016-03-31 Add0.71%$359.68 - $542.87
($414.39)
$ 423.222%Add 38.98%3,169,490
REGNRon Baron 2016-03-31 Reduce-0.01%$359.68 - $542.87
($414.39)
$ 423.222%Reduce -32.86%5,011
REGNJoel Greenblatt 2016-03-31 Reduce-0.01%$359.68 - $542.87
($414.39)
$ 423.222%Reduce -39.26%2,525
REGNMario Gabelli 2016-03-31 Reduce$359.68 - $542.87
($414.39)
$ 423.222%Reduce -2.54%1,343
REGNKen Fisher 2016-03-31 Reduce$359.68 - $542.87
($414.39)
$ 423.222%Reduce -0.33%613
REGNVanguard Health Care Fund 2015-12-31 Reduce-0.17%$459.82 - $587.09
($543.11)
$ 423.22-22%Reduce -6.84%2,280,494
REGNJoel Greenblatt 2015-12-31 Buy 0.02%$459.82 - $587.09
($543.11)
$ 423.22-22%New holding4,157
REGNKen Fisher 2015-12-31 Add$459.82 - $587.09
($542.9)
$ 423.22-22%Add 22.02%615
REGNMario Gabelli 2015-12-31 Reduce$459.82 - $587.09
($543.11)
$ 423.22-22%Reduce -35.76%1,378
REGNVanguard Health Care Fund 2015-09-30 Reduce-0.32%$451.82 - $592.4
($537.03)
$ 423.22-21%Reduce -11.45%2,447,894
REGNRon Baron 2015-09-30 Reduce$451.82 - $592.4
($537.03)
$ 423.22-21%Reduce -0.21%7,463
REGNKen Fisher 2015-09-30 Reduce$451.82 - $592.4
($537.03)
$ 423.22-21%Reduce -10.80%504
REGNVanguard Health Care Fund 2015-06-30 Reduce-0.15%$438.27 - $539.4
($487.44)
$ 423.22-13%Reduce -5.36%2,764,540
REGNKen Fisher 2015-06-30 Add$438.27 - $539.4
($487.44)
$ 423.22-13%Add 5.81%565
REGNMario Gabelli 2015-06-30 Reduce$438.27 - $539.4
($487.44)
$ 423.22-13%Reduce -2.05%2,145
REGNRon Baron 2015-06-30 Reduce$438.27 - $539.4
($487.44)
$ 423.22-13%Reduce -0.15%7,479
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

REGN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


REGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GOLDSTEIN JOSEPH LDirector 2016-07-29Sell2,125$425-0.42view
Sanofi10% Owner 2016-06-14Buy64,731$363.8616.31view
RYAN ARTHUR FDirector 2016-05-24Sell1,000$396.646.7view
Van Plew Daniel PEVP & General Mgr Industrial O 2016-05-18Sell4,413$385.779.71view
GOLDSTEIN JOSEPH LDirector 2016-04-06Sell2,000$425-0.42view
GOLDSTEIN JOSEPH LDirector 2016-03-21Sell2,000$37512.86view
Sanofi10% Owner 2016-02-17Buy161,157$392.467.84view
Sanofi10% Owner 2016-01-12Buy83,938$465.04-8.99view
McCorkle Douglas SVP Controller and Asst Treasur 2015-12-29Sell3,954$552.08-23.34view
BROWN MICHAEL SDirector 2015-12-10Sell3,000$546.45-22.55view

Quarterly/Annual Reports about REGN:

News about REGN:

Articles On GuruFocus.com
3 of Frank Sands' Top 5 Transactions in 2nd Quarter Were Reductions Aug 14 2016 
Edward Owens Top 2nd Quarter Investments Aug 03 2016 
Frank Sands Sells Visa, Baidu, Alibaba May 24 2016 
Baron Funds Comments on Regeneron Pharmaceuticals May 23 2016 
Market-Beating Vanguard Health Care Fund Adds Shares to 5 Positions May 03 2016 
Vanguard Boosts Stake in Incyte in 1st Quarter May 02 2016 
Amgen: Should I Just Sit and Wait? Mar 18 2016 
Weekly CFO Sells Highlights: Facebook, Fitbit, Regeneron Pharmaceuticals Nov 23 2015 
The Best-Performing Stocks Among Vanguard Health Care Fund's Holdings Nov 04 2015 
Weekly CFO Sells Highlight: Acadia Healthcare, Facebook, Regeneron Pharmaceuticals Aug 24 2015 

More From Other Websites
Regeneron Stock Up on BARDA Deal for MERS Antibodies Aug 23 2016
ETF’s with exposure to Regeneron Pharmaceuticals, Inc. : August 22, 2016 Aug 22 2016
8:31 am Regeneron Pharma announces agreement with the BARDA to manufacture and study two antibody... Aug 22 2016
Regeneron Announces Agreement with BARDA for the Manufacturing and Testing of New Antibodies Against... Aug 22 2016
Hunting For Biotech Stocks? Understand The Earnings Formula First Aug 19 2016
No Pain, Potential for Lots of Gain Aug 19 2016
Amgen, Sanofi Cholesterol Drugs Not Cost-Effective, Study Says Aug 16 2016
3 of Frank Sands' Top 5 Transactions in 2nd Quarter Were Reductions Aug 14 2016
The Zacks Analyst Blog Highlights: Regeneron, BioMarin, AbbVie, Amgen and Biogen Aug 12 2016
How to Play a Nasdaq Breakout Aug 12 2016
Biotech Stock Roundup: Earnings in Focus, AbbVie Takes Steps to Block Humira Copycat Aug 11 2016
Hall of Famer Dan Marino on his investments Aug 11 2016
ETF’s with exposure to Regeneron Pharmaceuticals, Inc. : August 11, 2016 Aug 11 2016
REGENERON PHARMACEUTICALS INC Financials Aug 11 2016
Adverum (ADVM) Reports Narrower-than-Expected Q2 Loss Aug 11 2016
Regeneron Pharmaceuticals, Inc. :REGN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9,... Aug 09 2016
What Do Analysts Recommend for Regeneron after 2Q16 Earnings? Aug 09 2016
How Did Regeneron Perform in 2Q16? Aug 08 2016
How Did Regeneron’s Revenue and Earnings Look in 2Q16? Aug 08 2016
Regeneron: The Downside of High Expectations Aug 05 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)